COMPOUND 19

CAS: 1383716-46-8

Ref. 3D-BC177726

Produktinformation

• Name: COMPOUND 19

Beschreibung

COMPOUND 19 is a selective, active analogue of the antimicrobial agent moxifloxacin. COMPOUND 19 has been shown to have inhibitory effects on cancer cells such as MCF-7 and MDA-MB-231, which are associated with breast cancer. In addition, COMPOUND 19 has been shown to be an α7 nicotinic acetylcholine receptor agonist that can induce apoptosis in these cells. It also inhibits the adenosine A3 receptor and mitochondrial membrane potential, which are both important in tumorigenesis. This compound is also effective against infectious diseases such as influenza and HIV. COMPOUND 19 may also be used to treat other types of cancers, including colon cancer and prostate cancer.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 421.42 g/mol
• Formel: C₁₉H₂₂F₃N₇O
• Reinheit: Min. 95%